US equities are trading higher on Friday at midday, after achieving a fourth straight month of gains on Thursday. Energy is the best performing sector, while hardware and semis are driving tech upside following Dell’s ($DELL)stellar earnings. Big tech is mixed and regional banks are weak following New York Community Bancorp’s ($NYCB)update today. Treasuries are…
Indie Semiconductor, Inc. (INDI) is an automotive software solutions and semiconductor company has been also known for accelerating vehicle electrification and recently reported Q4 earnings last week citing a record $70M in fourth quarter revenues as overall 2023 revenues were $223.2M, up 101% year-over-year. Other notable highlights from the release included being recognized by Morgan…
In a day filled with comments from Federal Reserve officials, stocks, bonds, and the dollar experienced slight fluctuations as traders sought insights into the Fed’s future moves. Equities remained close to record highs, buoyed by the recent AI-driven market surge that has left many analysts racing to revise their forecasts. The market’s focus is now…
New York Community Bancorp’s stocks experienced a 20% decline following the revelation of internal control problems. A change in CEO has also been announced with immediate effect. Goodrx saw an increase in shares of 5.4% after JPMorgan upgraded its digital healthcare platform from neutral to overweight, dismissing concerns about a changing pharmacy reimbursement model. GoodRx’s…
The Paramount+ logo is seen on a smartphone. Pavlo Gonchar | SOPA Images | LightRocket | Getty Images Stay updated on the companies creating buzz in midday trading. Hormel Foods — Stocks skyrocketed by 13.3% following the food processing company surpassing fiscal first-quarter earnings and revenue expectations. An impressive earnings of 41 cents per share…
US equities are trading higher on Thursday at midday, with small-caps extending the week’s outperformance. Big tech is mostly higher and other outperformers include semis, banks, media, crypto-linked names, autos, metals/miners, and REITs. Pharma, MedTech, payments, fertilizers, and hotels are underperforming. Treasuries are firmer, the Dollar index is down (0.2%), Gold is up +0.6%, Bitcoin…
Not only is Establishment Labs Holdings Inc. (ESTA) up 24% today, it’s also been steadily rising since the start of the year. The company who has been included in the PRISM Women’s Health Index since the indices’ inception on January 4th of this year, had traded around $25/share and is now approaching $50 with a…
The Federal Reserve’s preferred inflation metric aligns with economist predictions, sparking hopes for a potential rate cut by June. Wall Street experiences relief as the personal consumption expenditures index meets forecasts, signaling a controlled inflation scenario within expectations. Despite the PCE index remaining above the Fed’s 2% target, the latest data has mitigated fears of…
Enveric Biosciences (NASDAQ:ENVB), a biotechnology company focused on developing neuroplastogenic small-molecule therapeutics for mental health conditions announced the signing of three non-binding term sheets with an undisclosed biotechnology entity, aimed at out-licensing three distinct classes of compounds from its extensive library. This library, containing over 1,000 novel molecules, has been developed through Enveric’s innovative Psybrary™…
LivePerson, Inc. (LPSN) needs some resuscitation as it drags the PRISM NextGen Tech & AI Index today as its largest detractor, down ~42%. The company announced Q4 earnings reporting a quarterly loss of $0.18 per share that missed analysts estimates. Unfortunately their pulse continued to slow on Q1 guidance on revenues ($79-$83M vs Factset $94.4M)…
Adial Pharmaceuticals Inc (NASDAQ:ADIL) revealed that the United States Patent and Trademark Office issued patent number 11,905,562 on February 20, 2024. This new patent encompasses Adial’s flagship investigational drug, AD04, specifically its capacity to engage the serotonin transporter gene, aiming at the potential management of opioid use disorder (OUD). Highlighting the impact of this development,…
Leading cannabinoid and psychedelic medicine biotechnology company, Incannex Healthcare (Nasdaq: IXHL), has achieved positive topline results in its Phase 2 clinical trial of psilocybin in generalized anxiety disorder (GAD). Incannex President and CEO, Joel Latham, said, “This is the first time psilocybin has been investigated for treatment of generalized anxiety disorder, and the reduction in…